Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL390291 | 1.00 | ADRB2 (0.36) | ADRB2ADRB1ADRB3ATMTSHR | |
| SCHEMBL4770162 | 0.89 | ADRB2 (0.32) | ADRB2ADRB1ADRB3ATM | |
| SCHEMBL4770156 | 0.89 | ADRB2 (0.32) | ADRB2ADRB1ADRB3ATM | |
| SCHEMBL387710 | 0.84 | — | — | |
| SCHEMBL387709 | 0.84 | — | — | |
| SCHEMBL5695274 | 0.82 | LPAR2 (0.34) | LPAR2LPAR3LPAR1 | |
| SCHEMBL389689 | 0.81 | TSHR (0.39) | ADRB2ADRB1ADRB3ATMTSHR | |
| SCHEMBL5695211 | 0.81 | LPAR3 (0.37) | TSHRLPAR2LPAR3LPAR1CA1 | |
| SCHEMBL2282793 | 0.78 | TSHR (0.36) | ADRB2ADRB1ADRB3TSHRHPGD | |
| SCHEMBL2286290 | 0.78 | TSHR (0.36) | ADRB2ADRB1ADRB3TSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101697-B2 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | VCL, PUF60, JMJD6 | ADRB2 4769/4885ADRB1 4682/4885ADRB3 4428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.